Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes
The medication is sometimes prescribed off-label for weight loss and chronic weight management
This is the starting dose regardless of what semaglutide dose you were on even if you were at 2mg Ozempic or 2.4mg Wegovy
Wegovy and Ozempic, which both contain semaglutide, begin at much lower dosages of 0.25 mg weekly
Unfortunately, that's not how it works
Driven by a massive, consistent, year-round global market demand within weight management clinics, commercial healthcare networks, and specialized bariatric care centers, this premium localized lipase inhibitor stands as an incredibly stable, high-turnover inventory asset for international B2B buyers and contract distributors
